IRADIMED CORPORATION - COMMON STOCK
56,24
21-февраля-25 15:45:00
15 мин. задержка
Акции
-0,90
-1,58%
Сегодняшний диапазон
55,90 - 58,02
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd
26 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Participate at Upcoming Investor Conferences
06 сен 2023 15:00:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Second Quarter 2023 Financial Results
03 авг 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2023 Second Quarter Financial Results Conference Call on August 3rd
27 июл 2023 07:45:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Named a 2023 Best Small Company in America by Forbes
10 май 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
04 май 2023 07:30:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
27 апр 2023 07:30:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
06 мар 2023 07:45:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Issues Urgent Medical Device Correction
24 фев 2023 15:15:00 Источник Nasdaq GlobeNewswire
-
02 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
26 янв 2023 09:30:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
18 янв 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
03 ноя 2022 06:00:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
27 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
10 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
06 окт 2022 15:05:00 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
29 июл 2022 10:00:10 Источник Nasdaq GlobeNewswire
-
28 июл 2022 12:56:57 Источник Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
22 июл 2022 15:30:00 Источник Nasdaq GlobeNewswire
-
IRADIMED Names John F. Glenn Chief Financial Officer
26 май 2022 15:05:00 Источник Nasdaq GlobeNewswire